← brief for 2026-11-12 · Transplant & xeno
Sodium Bicarbonate and Non-HLA Autoantibody or HLA Antibody Trajectories in Long-term Kidney Transplant Recipients With Metabolic Acidosis: A Post Hoc Analysis of the Preserve-Transplant Randomized Controlled Trial.
Key takeaways
This is a follow-up look at a trial of sodium bicarbonate in kidney transplant patients. It checked how certain antibodies changed over time. The record does not state the number of people or the study length. It suggests a link between acid levels and antibody changes.
Who did this work
Ritter A (Division of Nephrology, University Hospital Zurich, Zurich, Switzerland.) · Nilsson J (Department of Immunology, University Hospital Zurich, Zurich, Switzerland.) · West E (Biostatistics at Clinical Trials Unit, HOCH Cantonal Hospital St.Gallen, St. Gallen, Switzerland.) · Kuhn C (Division of Nephrology and Transplantation Medicine, HOCH Cantonal Hospital St.Gallen, St. Gallen, Switzerland.) · Wagner CA (Institute of Physiology and Zurich Kidney Center, University of Zurich, Zurich, Switzerland.) · Schachtner T (Division of Nephrology, University Hospital Zurich, Zurich, Switzerland.) · Mohebbi N (Division of Nephrology, University Hospital Zurich, Zurich, Switzerland.)
Source
Article · Europe PMC, CKD · 2026-11-06
https://doi.org/10.1097/txd.0000000000002022